Skip to main content

Table 1 Association between clinicopathological variables and CNDP2 expression in 150 patients with CC

From: Up-regulation of CNDP2 facilitates the proliferation of colon cancer

Variables

n (%)

CNDP2 expression

Pvalue

  

Low

High

 

Age — yr

Mean 57.5

56.2 ± 10.7

58.5 ± 9.5

0.894a

Gender—n (%)

    

Male

76 (50.7)

29 (44.6)

47 (55.3)

0.195b

Female

74 (49.3)

36 (55.4)

38 (44.7)

 

Tumour size —n (%)

  

≤ 5 cm

44 (29.3)

22 (33.3)

22 (26.2)

0.340b

> 5 cm

106 (70.7)

44 (66.7)

62 (73.8)

 

Lymph nodes metastasis—n (%)

    

No

76 (50.7)

38 (57.6)

38 (45.2)

0.134b

Yes

74 (49.3)

28 (42.4)

46 (54.8)

 

Tumour grade—n (%)

    

1

20 (21.5)

8 (32.4)

12 (7.1)

0.434b

2

106 (53.9)

50 (46.0)

56 (64.3)

 

3

24 (24.6)

8 (21.6)

16 (28.6)

 

Tumor stage—n (%)

    

I

24 (16.0)

12 (18.2)

12 (14.2)

0.927b

II

46 (30.7)

20 (30.3)

26 (31.0)

 

III

62 (41.3)

26 (39.4)

36 (42.9)

 

IV

18 (12.0)

8 (12.1)

10 (11.9)

 

CEA—n (%)

    

Negative

96 (64.0)

44 (63.8)

52 (64.2)

0.956b

Positive

54 (36.0)

25 (36.2)

29 (35.8)

 

Tumor location—n (%)

RCC

84 (56.0)

28 (42.4)

56 (66.7)

0.003b*

LCC

66 (44.0)

38 (57.6)

28 (33.3)

 

RCC—n (%)

Male

42 (50.0)

9 (33.3)

33 (57.9)

0.035b*

Female

42 (50.0)

18 (66.7)

24 (42.1)

 

LCC—n (%)

Male

34 (51.5)

20 (52.6)

14 (50.0)

0.833b

Female

32 (48.5)

18 (47.4)

14 (50.0)

 
  1. aMann-whitney u test.
  2. bPearson Chi-Square test.
  3. *Statistically significant.